PharmaEssentia Corporation PharmaEssentia Corporation

PharmaEssentia Corporation

6446

Classifica tra le azioni #1425
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Prezzo delle azioni
$36.27
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$15.00B
Variazione (1 giorno)
-1.24%
Variazione (1 anno)
140.82%
Paese
TW
Scambia PharmaEssentia Corporation (6446)

Categoria

Healthcare
Storico del prezzo dell'azione per PharmaEssentia Corporation (6446)
Prezzo di chiusura più alto: $37.62 il 2026-10-01

Prezzo di chiusura più basso: $4.95 il 2014-03-01
Storico del prezzo dell'azione di PharmaEssentia Corporation dal 2014 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 77.91%
2025 -1.54%
2024 65.30%
2023 -34.57%
2022 52.79%
2021 220.53%
2020 2.39%
2019 -41.63%
2018 21.23%
2017 -8.25%
2016 -3.31%
2015 21.68%
2014 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$161.15 20.52%
DE
$40.25 42.39%
JP
$212.49 24.09%
CH
$19.19 -0.09%
IN